Orca Bio to Present at the 39th Annual J.P. Morgan Healthcare Conference

MENLO PARK, CA, January 6, 2021 – Orca Bio, a clinical-stage biotechnology company developing high-precision cell therapies for patients with blood diseases, today announced that Ivan Dimov, PhD, Chief Executive Officer, will present a company overview at the 39th Annual J.P. Morgan Healthcare Conference. The presentation will be held virtually on Monday, January 11, 2021, at 1:55 PM PT (4:55 PM ET), immediately followed by a Q&A session.

Management will be available for meetings during the week of the conference.

Orca Bio to Present at the 40th Annual J.P. Morgan Healthcare Conference

MENLO PARK, CA, Jan. 6, 2022 – Orca Bio, a clinical-stage biotechnology company developing purified, high-precision cell therapies for the treatment of cancer, autoimmune diseases and genetic blood disorders, today announced that Ivan Dimov, Ph.D., Orca Bio’s chief executive officer and co-founder, will present at the 40th Annual J.P. Morgan Healthcare Conference.

The company presentation will take place virtually on Tuesday, January 11, 2022, at 6:30 AM PST (9:30 AM EST).